Dr Sharon Glynn
Dr. Sharon Glynn is Lecturer Above the Bar in Pathology at NUI Galway. She was awarded a Science Foundation Ireland Career Development Award in 2018 for her research into the role of nitrosative stress and human endogenous retroviruses (HERV-K) in the development of high grade prostate and breast cancer. Her current work is focused on elucidating the role of inflammation pathways particularly in the progression of metastatic prostate cancer and triple negative breast cancer. Dr. Glynn has authored over 43 papers in peer reviewed journals and has also received numerous grants from Breast Cancer Now and the Irish Cancer Society. She graduated in 2003 with a BSc in Biotechnology from Dublin City University. After graduation Dr. Glynn served as a research officer at the National Institute for Cellular Biotechnology in Dublin City University where she studied the efficacy of new therapeutics including cholesterol lowering statins on breast cancer and melanoma proliferation and invasion. From 2005 to 2009 Dr. Glynn worked as an NCI Cancer Prevention Fellow in Bethesda Maryland, USA in the Laboratory of Human Carcinogenesis under the mentorship of Dr. Stefan Ambs, studying the role of inflammation pathways in estrogen receptor negative breast cancer progression using an approach combining molecular epidemiology and basic laboratory science. She discovered a novel role for NOS2 in ER negative and basal-like breast cancer progression. Dr. Glynn also discovered a polymorphism in the SOD2 gene predicative of response to cyclophosphamide containing chemotherapeutic regimens in breast cancer cases, receiving an NIH Fellows Award for Research Excellence for this work. In September 2009 Dr. Glynn moved to the Radiation Biology Branch at the NCI, to continue working with Dr. David Wink. During this time she was awarded a Keystone Symposia Scholarship for her work. From September 2010 to December 2014 Dr. Glynn was the Director of Laboratory Research at the Prostate Cancer Institute at NUI Galway.